To test whether this immune tolerance could be overcome by an immune system that did not coevolve with the primary tumor, we again generated independent primary p53/MCA sarcomas, amputated the tumor-bearing limb from donor mice when the tumors reached ~70 mm3, and generated cell lines from each amputated tumor. This evidence concerns the gene TP53 and neoplasm.